Acesso livre
Acesso livre

Terapia Intensiva

Diretriz rápida NICE COVID-19 | Trombocitopenia trombótica imune induzida por vacina.

2 Ago, 2021 | 18:37h

COVID-19 rapid guideline: vaccine-induced immune thrombocytopenia and thrombosis – National Institute for Health and Care Excellence

Comunicado de imprensa: NICE publishes new rapid guideline to diagnose and treat rare blood clotting condition associated with COVID-19 vaccination – National Institute for Health and Care Excellence

Conteúdo relacionado: Very rare cases of thrombosis with thrombocytopenia syndrome (TTS) after AstraZeneca vaccine: a global safety database analysis – the estimated rate of TTS after the first dose was 8.1 per million vaccinees; after the second dose, the estimated rate was 2.3 per million vaccinees. (vários artigos e fontes sobre o tema)

Trombocitopenia trombótica imune induzida por vacina: o que se sabe e o que não se sabe.

2 Ago, 2021 | 18:33h

Vaccine-induced immune thrombotic thrombocytopenia: what we know and do not know – Blood

Conteúdo relacionado: Very rare cases of thrombosis with thrombocytopenia syndrome (TTS) after AstraZeneca vaccine: a global safety database analysis – the estimated rate of TTS after the first dose was 8.1 per million vaccinees; after the second dose, the estimated rate was 2.3 per million vaccinees. (vários artigos e fontes sobre o tema)

Risco de infarto agudo do miocárdio e AVC isquêmico após COVID-19 na Suécia – “o risco real é aumentado em 3 a 8 vezes para o infarto agudo do miocárdio e entre 3 e 7 vezes para o AVC isquêmico após COVID-19.”

2 Ago, 2021 | 18:27h

Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study – The Lancet

Comentário convidado: What is the association of COVID-19 with heart attacks and strokes? – The Lancet

 

Comentário no Twitter

 

Estudo | Abordagens recomendadas para minimizar a dispersão por aerossol do SARS-CoV-2 durante o suporte ventilatório não invasivo podem deteriorar o desempenho do ventilador.

2 Ago, 2021 | 18:16h

Study Recommended Approaches to Minimize Aerosol Dispersion of SARS-CoV-2 During Noninvasive Ventilatory Support Can Cause Ventilator Performance Deterioration: A Benchmark Comparative Study – CHEST

Editorial: Circuit Set-ups to Reduce Virus Aerosolization During Noninvasive Positive Pressure Ventilation: Dancing in the Dark

Diretrizes brasileiras sobre angina instável e infarto agudo do miocárdio sem elevação do segmento ST – 2021.

2 Ago, 2021 | 18:15h

Brazilian Society of Cardiology Guidelines on Unstable Angina and Acute Myocardial Infarction without ST-Segment Elevation – 2021 – Arquivos Brasileiros de Cardiologia (PDF)

Revisão | Mudança de paradigmas no tratamento da diverticulite aguda não complicada.

2 Ago, 2021 | 17:55h

Changing Paradigms in the Management of Acute Uncomplicated Diverticulitis – Scandinavian Journal of Surgery

Conteúdo relacionado:

RCT: Another study shows that non-antibiotic outpatient treatment in mild acute diverticulitis is safe.

Review: Elective surgical management of diverticulitis

State of the Art Review | Management of colonic diverticulitis

Drains, germs, or steel: Multidisciplinary management of acute colonic diverticulitis

Randomized trial: Laparoscopic lavage vs. primary resection for perforated purulent diverticulitis; similar long-term results, but recurrence was more common after laparoscopic lavage

Randomized trial: In patients with recurrent, complicated, or persistent painful diverticulitis, sigmoid resection improved quality of life but was associated with a small but significant risk of major complications

Systematic review: Management of colonic diverticulitis

WSES Guidelines for the Management of Acute Colonic Diverticulitis

ASCRS Guidelines for the Treatment of Left-Sided Colonic Diverticulitis

 

Comentário no Twitter

 

Novidades na terapia intensiva: sustentabilidade ambiental.

2 Ago, 2021 | 17:50h

What’s new in intensive care: environmental sustainability – Intensive Care Medicine

Revisão sistemática | Não há evidências que suportem o uso de ivermectina no tratamento ou na prevenção de COVID-19.

2 Ago, 2021 | 17:48h

Ivermectin for preventing and treating COVID‐19 – Cochrane Library

Resumo: Ivermectin for preventing and treating COVID-19 – Cochrane Library

Comentário: Ivermectin treatment in humans for COVID-19 – Liverpool School of Tropical Medicine

Conteúdos relacionados:

Why was a major study on ivermectin for covid-19 just retracted?

RCT: Ivermectin does not prevent hospitalizations in patients with COVID-19.

Ivermectin for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials – “IVM did not reduce all-cause mortality, length of stay or viral clearance in RCTs in COVID-19 patients with mostly mild disease”.

Ivermectin is the new hydroxychloroquine, take 2 – “Ivermectin shouldn’t be used to treat COVID-19 outside of the context of a well-designed clinical trial”.

Therapeutics and COVID-19 | WHO guideline update advises Ivermectin should only be used to treat COVID-19 within clinical trials

RCT: Ivermectin does not improve time to resolution of symptoms among adults with mild COVID-19

M-A | Prevalência global da intenção de deixar o trabalho entre enfermeiros de terapia intensiva – “27% dos enfermeiros de terapia intensiva têm intenção de mudar de área.”

2 Ago, 2021 | 17:22h

Global prevalence of turnover intention among intensive care nurses: A meta-analysis – Nursing in Critical Care (link para o resumo – $ para o texto completo)

 

Comentário no Twitter

 

Análise das evidências | Piperacilina-tazobactam é segura em pacientes alérgicos à penicilina?

2 Ago, 2021 | 17:20h

Is piperacillin-tazobactam safe in patients with penicillin allergy? – PulmCrit

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.